COSA 2015* , ,
Presentations this author is a contributor to:
Randomised phase 3 trial of enzalutamide in first line androgen deprivation therapy for metastatic prostate cancer: the ANZUP ENZAMET Trial (ANZUP 1304) (#269)
3:00 PM
Ian Davis
Posters1